A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT04298918 · TERMINATED
Trial details
- NCT number
- NCT04298918
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2021-02-04
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.